Tamoxifen Fails to Deliver on Clinical Promise for Duchenne Muscular Dystrophy
Phase III trial finds that repurposed tamoxifen was safe but ineffective
Source: medpagetoday.com
Motor Function Measure News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Motor Function Measure. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Motor Function Measure Today - Breaking & Trending Today
Biohaven Completes Enrollment in Pivotal Phase 3 Study of Taldefgrobep Alfa in Spinal Muscular Atrophy
/PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN) ("Biohaven"), a global clinical-stage biopharmaceutical company focused on the discovery, development and...
Source: prnewswire.com
Risdiplam May Be Safe and Effective in SMA Care
Risdiplam appears to be an effective therapeutic option for patients with spinal muscular atrophy, leading to improved motor function, a study found.
Source: neurologyadvisor.com
Taysha Faces Stock Delisting, Scraps $75M Durham Manufacturing Facility
Taysha Gene Therapies faces potential delisting of its shares—the latest in a series of setbacks that include scrapping a $75-million manufacturing facility in Durham, NC.
Source: genengnews.com
Genentech Announces Industry-Leading Brain Health Research Collaborations and Latest Data Across Neuroscience Medicines at AAN 2023 Annual Meeting
–– Roche, Genentech and partners embark on global prevalence research, trend-spotting with digital analysis, and telehealth initiatives to assess & address deterrents to brain health... | June 18, 2023
Source: marketscreener.com